<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04208035</url>
  </required_header>
  <id_info>
    <org_study_id>2018-4503</org_study_id>
    <nct_id>NCT04208035</nct_id>
  </id_info>
  <brief_title>Hepatitis C Elimination in the Netherlands</brief_title>
  <acronym>CELINE</acronym>
  <official_title>Hepatitis C Elimination in the Netherlands (CELINE) - A National Multicenter Cohort Study Retrieving Lost to Follow-up Chronic Hepatitis C Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Radboud University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Gilead Sciences</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Radboud University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of CELINE is to retrieve and re-evaluate lost to follow-up chronic hepatitis C
      patients in the Netherlands.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 17, 2018</start_date>
  <completion_date type="Anticipated">January 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of lost to follow-up (LTFU) patients successfully re-linked to care</measure>
    <time_frame>End of study, on average 2.5 years after initiation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total number of LTFU patients in the investigated time period</measure>
    <time_frame>15 years prior to study initiation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Case ascertainment rate</measure>
    <time_frame>End of study, on average 2.5 years after initiation</time_frame>
    <description>Established contact (via telephone or in writing) with a patient who is eligible for retrieval</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Awareness of HCV diagnosis among LTFU patients</measure>
    <time_frame>End of study, on average 2.5 years after initiation</time_frame>
    <description>Number of patients who were aware of their HCV diagnosis when they are invited for re-evaluation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients who never had an outpatient appointment with a hepatologist or infectious disease specialist after initial positive HCV test</measure>
    <time_frame>End of study, on average 2.5 years after initiation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of viraemic patients at time of re-evaluation</measure>
    <time_frame>End of study, on average 2.5 years after initiation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Liver fibrosis stage of retrieved patients</measure>
    <time_frame>End of study, on average 2.5 years after initiation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reasons for becoming LTFU</measure>
    <time_frame>End of study, on average 2.5 years after initiation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time of being LTFU</measure>
    <time_frame>End of study, on average 2.5 years after initiation</time_frame>
    <description>Defined as years since last (HCV-)related hospital visit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mode of HCV transmission</measure>
    <time_frame>End of study, on average 2.5 years after initiation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sustained virological response</measure>
    <time_frame>End of study, on average 2.5 years after initiation</time_frame>
    <description>Defined as the absence of HCV RNA at least 12 weeks after treatment</description>
  </secondary_outcome>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Chronic Hepatitis c</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Lost to follow-up (possibly) chronically HCV-infected patients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ever diagnosed with (possible) chronic HCV in the 15-year period prior to initiation
             of the study, defined as having had a positive anti-HCV or HCV RNA test

          -  Lost to follow-up, defined as the lack of a scheduled outpatient care appointment
             after the last known positive HCV test result

        Exclusion Criteria:

          -  Younger than 18

          -  Deceased

          -  Not residing in the Netherlands

          -  Unknown current address

          -  Severe comorbidity or short life expectancy that limits patients from benefiting from
             retrieval
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joost Drenth, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Radboud University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marleen van Dijk, MD</last_name>
    <phone>0034243613999</phone>
    <email>marleen.vandijk@radboudumc.nl</email>
  </overall_contact>
  <location>
    <facility>
      <name>Radboudumc</name>
      <address>
        <city>Nijmegen</city>
        <state>Gelderland</state>
        <zip>6500 HB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marleen van Dijk, MD</last_name>
      <phone>0031243613999</phone>
      <email>marleen.vandijk@radboudumc.nl</email>
    </contact>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>December 6, 2019</study_first_submitted>
  <study_first_submitted_qc>December 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 23, 2019</study_first_posted>
  <last_update_submitted>December 18, 2019</last_update_submitted>
  <last_update_submitted_qc>December 18, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 23, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Radboud University</investigator_affiliation>
    <investigator_full_name>Joost Drenth</investigator_full_name>
    <investigator_title>Professor, MD, PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hepatitis A</mesh_term>
    <mesh_term>Hepatitis C</mesh_term>
    <mesh_term>Hepatitis C, Chronic</mesh_term>
    <mesh_term>Hepatitis</mesh_term>
    <mesh_term>Hepatitis, Chronic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

